Literature DB >> 12702548

Influence of systemic inflammatory response syndrome and sepsis on outcome of critically ill infected patients.

Corinne Alberti1, Christian Brun-Buisson, Sergey V Goodman, Daniela Guidici, John Granton, Rui Moreno, Mark Smithies, Oliver Thomas, Antonio Artigas, Jean Roger Le Gall.   

Abstract

The clinical significance of the systemic inflammatory response in infected patients remains unclear. We examined risk factors for hospital mortality in 3,608 intensive care unit patients included in the European Sepsis Study. Patients were categorized as having infection without or with (i.e., sepsis) systemic inflammatory response, severe sepsis, and septic shock, on the first day of infection. Hospital mortality varied from 25 to 60% according to sepsis stage, but did not differ between the first two categories (hazard ratio, 0.94; p = 0.55), whereas there was a grading of severity from sepsis to severe sepsis (1.53, p < 10-4) and septic shock (2.64, p < 10-4). Within each stage, mortality was unaffected by the number of inflammatory response criteria. Prognostic factors identified by Cox regression included comorbid conditions, severity of acute illness and acute organ dysfunction, shock, nosocomial infection, and infection caused by aerobic gram-negative bacilli, enterobacteria, Staphylococcus aureus, and infection from a digestive or unknown source. We conclude that whereas the categorization of infection by the presence of organ dysfunction or shock has strong prognostic significance, infection and sepsis have similar outcomes, unaffected by the presence or number of inflammatory response criteria. Refinement of risk stratification of patients presenting with infection and no organ dysfunction is needed.

Entities:  

Mesh:

Year:  2003        PMID: 12702548     DOI: 10.1164/rccm.200208-785OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  75 in total

1.  A global perspective on the epidemiology of sepsis.

Authors:  Marc Moss; Gregory S Martin
Journal:  Intensive Care Med       Date:  2004-02-24       Impact factor: 17.440

2.  Chronic kidney disease worsens sepsis and sepsis-induced acute kidney injury by releasing High Mobility Group Box Protein-1.

Authors:  Asada Leelahavanichkul; Yuning Huang; Xuzhen Hu; Hua Zhou; Takayuki Tsuji; Richard Chen; Jeffrey B Kopp; Jürgen Schnermann; Peter S T Yuen; Robert A Star
Journal:  Kidney Int       Date:  2011-08-10       Impact factor: 10.612

3.  Use of blood urea nitrogen, creatinine, interleukin-6, granulocyte-macrophage colony stimulating factor in combination to predict the severity and outcome of abdominal sepsis in rats.

Authors:  Min Gao; Lingli Zhang; Ying Liu; Mingshi Yang; Nian Wang; Kangkai Wang; Danmin Ou; Meidong Liu; Guangwen Chen; Ke Liu; Xianzhong Xiao
Journal:  Inflamm Res       Date:  2012-05-29       Impact factor: 4.575

4.  Incidence of sepsis in hospitalized patients.

Authors:  Rui Moreno; Susana Afonso; Teresa Fevereiro
Journal:  Curr Infect Dis Rep       Date:  2006-09       Impact factor: 3.725

5.  [Severe infections : causes and management of sepsis].

Authors:  B Salzberger; F Hanses; G Birkenfeld; J Langgartner
Journal:  Internist (Berl)       Date:  2013-08       Impact factor: 0.743

6.  The Severity of ICU-Acquired Pneumonia.

Authors:  Hugues Marechal; Nathalie Layios; Pierre Damas
Journal:  Curr Infect Dis Rep       Date:  2013-10       Impact factor: 3.725

Review 7.  Healthcare disparities in critical illness.

Authors:  Graciela J Soto; Greg S Martin; Michelle Ng Gong
Journal:  Crit Care Med       Date:  2013-12       Impact factor: 7.598

8.  Severe sepsis in two Ugandan hospitals: a prospective observational study of management and outcomes in a predominantly HIV-1 infected population.

Authors:  Shevin T Jacob; Christopher C Moore; Patrick Banura; Relana Pinkerton; David Meya; Pius Opendi; Steven J Reynolds; Nathan Kenya-Mugisha; Harriet Mayanja-Kizza; W Michael Scheld
Journal:  PLoS One       Date:  2009-11-11       Impact factor: 3.240

9.  Early drotrecogin alpha (activated) administration in severe sepsis is associated with lower mortality: a retrospective analysis of the Canadian ENHANCE cohort.

Authors:  Richard V Hodder; Richard Hall; James A Russell; Harold N Fisher; Bobbie Lee
Journal:  Crit Care       Date:  2009-05-20       Impact factor: 9.097

10.  Cell death serum biomarkers are early predictors for survival in severe septic patients with hepatic dysfunction.

Authors:  Stefan Hofer; Thorsten Brenner; Christian Bopp; Jochen Steppan; Christoph Lichtenstern; Jürgen Weitz; Thomas Bruckner; Eike Martin; Ursula Hoffmann; Markus A Weigand
Journal:  Crit Care       Date:  2009-06-18       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.